Peels

Peels is an award-winning CBD brand that stands out by offering products made from oranges, completely free of THC, hemp, or cannabis. The company utilizes proprietary technology to create bio-identical CBD from the terpenes naturally present in citrus peels. This approach has earned them recognition, including the Clean Label Project Purity Award in 2021 and certifications for being THC-free and pesticide-free. Founded in 2020, Peels operates within the consumer goods, health and wellness, manufacturing, and CRM and sales industries. The company aims to innovate in the CBD market, providing products that bring relief, ease stress, and aid with sleep. Their offerings, including oils, gummies, and immunity shots, are known for their purity and taste, resembling an orange creamsicle. Notably, their products are positioned as safe and reliable for a wide range of users, from athletes to teachers and first responders, due to the absence of THC. Peels’ unique value proposition resides in its utilization of natural elements combined with innovative scientific processes, making it an intriguing investment prospect within the rapidly evolving CBD industry. Although specific details about the company’s headquarters and latest investment are not available, Peels’ innovative approach and market potential make it a promising venture for potential investors seeking opportunities within the health and wellness sector.